New Delhi: India is developing its engagement with neighbour nations Bangladesh and Myanmar over coronavirus vaccine production.
The Indian delegation had visited Bangladesh on October 17 and 18 with the Ministry of External Affairs (MEA).
On the visit to Bangladesh, MEA said that “that both sides had fruitful discussions on the current stage of vaccine development in India and modalities of clinical trials in Bangladesh,”
“With Myanmar, a virtual interaction happened with key stakeholders from both sides present in the meeting,” The MEA said
“As the situation with respect to vaccine development evolves, the sides will discuss and decide on modalities of cooperation.” MEA added.
India’s foreign secretary Harsh Shringla had visited Bangladesh and Myanmar and cooperation to develop covid-19 vaccine was the key focus of the meet.
Myanmar had received a gift from India in which New Delhi had gifted 3000 vials of anti-COVID-19 medicine Remdesivir to State Counsellor Aung San Suu Kyi as a symbol of India‘s commitment to helping Myanmar mitigate the impact of the pandemic.
Army Chief General Manoj Mukund Naravane also visited Myanmar with Harsh Shringla.
In the United Nations General assembly, The Prime Minister of India – Narendra Modi had announced that India’s vaccine production and delivery capacity will be used to help all humanity in fighting the COVID-19 pandemic.
While India had already exported the medicines like HCQ, Paracetamol to more than 150 countries and it is also organising training to build capacity.
In fact, for the neighbourhood, India has organised two training modules in which about 90 health experts and scientists have participated.